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Abstract 
Objective: We examined consumer outcomes before and after implementing CommonGround, a 
computer-based shared decision-making program. Methods: Consumers with severe mental 
illness (n=167) were interviewed prior to implementation as well as 12 and 18 months later to 
assess changes in active treatment involvement, symptoms, and recovery-related attitudes. 
Providers also rated consumers on level of treatment involvement. Results: Most consumers 
used CommonGround at least once (67%), but few used the program regularly. Mixed effects 
regression analyses showed improvement in self-reported symptoms and recovery attitudes. 
Self-reported treatment involvement did not change, but for a subset with the same providers 
over time, the providers rated consumers as more active in treatment. Conclusions: This study 
adds to the growing literature on tools to support shared decision-making, showing the potential 
benefits of CommonGround for improving recovery outcomes. More work is needed to better 
engage consumers in CommonGround and to test the approach with more rigorous methods. 
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Medication management for people with severe mental illness (SMI) has historically 
been conceptualized as strategies to increase compliance. However, current focus attempts to 
incorporate person-centered, recovery-oriented care with effective medication management 
supporting consumer goals; this involves complex decision-making and requires a partnership 
between two experts, the consumer and the provider (1). This concept of shared decision-
making (SDM) is now widely recognized as an indicator of high-quality healthcare, with 
increasing calls for SDM in mental health settings (1). However, SDM is still relatively rare in 
mental health, and few studies have examined approaches specifically designed to increase 
SDM in these settings. 
Consumers with SMI desire a role in treatment decisions (2), but several barriers impede 
widespread use of SDM, including provider concerns of time constraints, questions of 
applicability for some consumers or clinical situations, and confusion around roles and 
responsibilities (3). Given barriers to SDM, decision-support tools may facilitate more effective 
and efficient clinical consultation, while promoting reciprocal exchange of information and 
preferences to improve consumer outcomes.  
One promising decision-support system is CommonGround, which integrates computer 
technology, decision-support tools, peer support, and provider and consumer training (4). Initial 
pilot work with CommonGround in people with SMI suggested improved consumer-provider 
communication, shared treatment decisions, and an increased focus on recovery-oriented goals 
(4-6). Two other CommonGround evaluations reported varied findings; the first showed 
significantly improved symptoms and functioning and fewer consumer concerns about side 
effects with use of CommonGround (7), but the second did not show improvements in 
medication adherence over 6-month follow-up (8). Taken together, more research is needed to 
investigate the impact of CommonGround on consumer outcomes. 
Within the CommonGround program, computer kiosks use technologically-advanced, 
self-guided discovery modules designed to assist individuals to learn about recovery, identify 
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strategies to reach recovery goals, and monitor and share progress. “Personal medicine” (self-
identified strategies that provide meaning and help consumers stay well) and a “power 
statement” (goals for psychiatric medication use in the recovery context) are developed in 
CommonGround (4). Prior to a psychiatric visit, consumers complete a one-page health report 
with assistance from peer providers that integrates a power statement and personal medicine 
with current symptoms and concerns to more facilitate more efficient communication with 
providers. The health report highlights the area(s) consumers most want to discuss during 
limited appointment times and assists in clarifying consumer and provider roles in the decision-
making process. CommonGround was designed to overcome common obstacles for people with 
SMI, such as low literacy, limited computer skills, and potentially elevated symptoms by 
providing peer-guided computer-based tools in accessible language (4). 
Our objective was to implement CommonGround in a new service setting -- an urban 
community mental health center (CMHC) -- and examine outcomes of consumers with SMI 
engaged in assertive community treatment (ACT) or outpatient services who had access to the 
program. Because CommonGround prompts consumers to take a greater role in treatment 
decisions, we expected consumers to report an increased desire for autonomy in treatment 
decisions and to show greater activation in treatment. Further, CommonGround provides 
concrete tools to identify and address medication concerns and to integrate personal medicine 
and consumer preference about medication in decision-making, which should contribute to 
reduced symptoms. Finally, given CommonGround’s emphasis on recovery, particularly with 
peer providers who model recovery (1), we hypothesized that consumers would report greater 
levels of recovery and hope. This study extends prior work by implementing the approach in a 
new setting and assesses a broader range of recovery-related consumer outcomes. 
Method 
 We implemented CommonGround in two outpatient clinics and two ACT teams serving 
adults with SMI in an urban CMHC. Due to staff turnover, there were eight different psychiatric 
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providers over the study period. Visits with providers generally entailed check-ins, medication 
management, and discussion of consumer concerns. The CommonGround program was offered 
at decision-support centers (DSCs) staffed by peer providers.  
Research assistants approached potential participants upon arrival for a psychiatric visit. 
The assistants described the study, screened interested participants, and completed an 
informed consent process. Eligibility included receipt of psychiatric services from the CMHC, 
English fluency, ability to provide informed consent, and willingness to be interviewed three 
times and have three psychiatric provider visits audiotaped (baseline, 12 months, and 18 
months). Consumers were not eligible if they were planning to leave the CMHC or change 
providers during the study timeframe. Assistants audiotaped the psychiatric visit and conducted 
an interview. Providers were asked to complete a brief measure assessing consumer 
involvement after the visit. One-year and 18-month interviews were scheduled to coincide with 
psychiatric appointments. Consumers were paid $20 for each interview. All procedures were 
approved by the [university] Institutional Review Board. 
We gathered demographic variables and obtained psychiatric diagnoses through agency 
records. The Patient Activation Measure (PAM-MH; 9) assessed activation in mental health 
treatment. The Autonomy Preference Index (API) assessed preferences related to autonomy in 
medical decision-making (10) using two subscales: information seeking and decision-making 
autonomy. We assessed symptoms using a subscale of the “How I am Doing” scale from the 
CommonGround program (7). We used the Recovery Assessment Scale (RAS; 24-item) to 
measure perceived level of recovery from psychiatric illness (11), and hope was assessed with 
the State Hope Scale (12). Providers rated consumer involvement in visits using a 6-item 
questionnaire developed for this study. Providers rated the extent to which the consumer and 
provider worked together in the session on a variable 4-point response scale. All measures 
have been used in this population before and had good reliability.  
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 Mixed effects regressions were used to examine changes in consumer outcomes over 
time, controlling for age, race, gender, and clinic type. Frequency of CommonGround health 
report completion, an indication of the intervention exposure intensity and the most critical 
indicator of program engagement (13), was also controlled. Further, for consumers who had the 
same psychiatric provider over 18 months (n=37), we examined whether the provider perceived 
changes in involvement over time. Because most consumers had different providers over time 
due to turnover, provider effects were not controlled. Multiple imputation was used for missing 
data.  
Results 
Over half of participating consumers were male (56.9%), African American (54.8%), and 
had completed high school or some college (58.1%). Most participants were diagnosed with 
schizophrenia (67.6%). There were 167 participants at baseline, 105 at 12 months, and 83 at 18 
months (50% dropout). Dropout was not significantly related to consumer demographics or 
baseline outcomes.  
Regarding intervention exposure, 60 people (36%) never completed a health report, 34 
(20%) completed one report, 24 (14%) completed two reports, 13 (8%) completed three reports, 
and 36 (22%) completed more than three reports during the study period. Among participants 
who were in the study for 18 months, those who had the same providers (n=37) completed the 
health report about twice as often (m=6.2±4.9) as those with different providers (m=2.5±1.6; 
t(42.5)=-4.42, p<.001).  
Consumer outcomes over time are shown in the Table. Self-reported patient activation 
and autonomy preferences did not change over time. However, consumers who had the same 
provider over 18 months showed significant improvement in provider perceptions of consumer 
involvement over time (β=.13). Among the entire sample, self-reported symptoms also improved 
over time (β=.08). Recovery attitudes showed significant improvement in RAS overall mean 
scores (β=.06) and the subscale “No domination by symptoms” (β=.15). Improvement in two 
8 
 
other RAS subscales was marginally significant: “Personal confidence and hope” (β=.06) and 
“Reliance on others” (β=.07). Hope did not change over time.  
Discussion 
 In this uncontrolled study, consumers reported improvements in symptoms and 
perceived recovery attitudes over time after implementing CommonGround in the context of 
ongoing mental health services. However, most measures of treatment involvement did not 
change. In addition, use of CommonGround was variable, with a large proportion (36%) never 
completing a health report. 
 In terms of positive changes in consumer outcomes, our findings are consistent with 
previous work showing improved symptoms and functioning in participants using 
CommonGround (7). The present study extends these findings by showing improvement on a 
recovery-related measure independent of the administrative data tracked in the 
CommonGround system. Another important contribution is that we examined the use of 
CommonGround in the context of both ACT and outpatient treatment teams. Given some of the 
uncertainty that has surrounded the feasibility of SDM with people with SMI (14), the present 
findings suggest that decision-aid technology with a support system that includes peer providers 
is promising for those involved in the most intensive community mental health services.  
 One unexpected finding in our study was the low rate of CommonGround health report 
completion across consumers overall. Given high levels of provider turnover during the study 
period and changing treatment team infrastructure, there were several barriers to 
implementation that likely influenced CommonGround use (15). Indeed, those who had the 
same providers completed the health report about twice as often as those with different 
providers, and these individuals showed positive changes in treatment involvement. It may be 
that provider consistency is an important mechanism that promotes both CommonGround use 
and consumer outcomes. Future work should seek strategies to support use of 
CommonGround, even in the face of turnover. 
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 There are several limitations to this study. First, without having a control group and 
experimental design, the causal influence of CommonGround for improved outcomes is not 
clear. Second, the study had a high rate of provider turnover; this impacted CommonGround 
use, as well as our ability to control for the provider effects over time. Third, we had a relatively 
high rate of consumer dropout and a low rate of health report completion. Future work is needed 
to investigate factors contributing to systemic and participant-level barriers to engaging in 
CommonGround, including understanding subgroups for whom the intervention may be most 
effective. Finally, we are limited in our interpretation of clinical significance by the relatively small 
effect sizes, which require further investigation.  
Overall, our study found additional positive recovery outcomes after CommonGround 
implementation for people who receive ACT and outpatient services in a CMHC, indicating 
potential benefits of the program for those receiving the most intensive outpatient services. 
More attention to facilitating consistent use of CommonGround and a more rigorous design to 
evaluate its causal influence are warranted.  
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Table  
Mixed Effects Regression Results 
  
Baseline 
(N=167) 
12 Month 
(N=105) 
18 Month 
(N=83)   
Variable M SD M SD M SD 
Significance 
(mixed 
effects reg.) 
Involvement               
 Patient Activation Measure 55.37 13.34 54.21 12.46 54.68 14.79 .57 
 API: Decision-making 2.42 .83 2.51 .91 2.45 1.04 .78 
 API: Information-seeking 4.39 .49 4.20 .54 4.27 .57 .59 
Providers' perception of consumer 
involvement (n = 37) 3.54 .42 3.65 .44 3.80 .36 .01 
Symptoms        
 HIAD (Symptom subscale) 3.53 .94 3.61 .95 3.69 .91 .02 
Recovery Attitudes        
 RAS: Total 3.84 .53 3.91 .64 3.97 .63 .02 
 RAS: Personal Confidence/ Hope 3.83 .65 3.88 .79 3.95 .74 .06 
 RAS: Willingness to ask for help 4.17 .68 4.22 .71 4.26 .68 .24 
 RAS: Goal and success orientation 4.11 .62 4.09 .75 4.13 .67 .74 
 RAS: Reliance on others 3.83 .75 3.78 .93 3.97 .78 .05 
 RAS: No domination by symptoms 3.13 .91 3.53 .94 3.44 1.01 <.01 
 Hope 2.91 .64 2.90 .66 2.95 .72 .55 
Note. API=Autonomy Preference Index. Mean scores range from one to five, with higher scores indicating 
greater preferences for autonomy in decision-making or information-seeking. HIAD=How I Am Doing scale. 
Mean scores range from one to five, with higher scores indicating less severe symptoms. RAS=Recovery 
Assessment Scale. Mean scores range from one to five, with higher scores indicating greater perceptions of 
recovery. The Patient Activation Measure has possible scores from 1 to 100, with higher scores indicating 
greater patient activation. The State Hope Scale has possible mean scores from one to five, with higher scores 
indicating greater hope. The scale to assess providers’ perceptions of consumer involvement has possible mean 
scores from one to four, with higher scores indicating greater involvement in the visit. 
 
 
